Bosentan Tablet
Product Images NDC 70771-1018

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bosentan (NDC 70771-1018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2eb3ff01 4e61 4397 8042 9ee532e72a80 09

2eb3ff01 4e61 4397 8042 9ee532e72a80 09
Bosentan Tablets 62.5 mg oral tablets label with NDC 70771-1017-6. The label shows a round, beige tablet with imprint '446'. The package contains 60 tablets and is labeled for prescription use only. The labeler is Zydus Lifesciences Limited. Storage and dosing instructions, barcode, and manufacturer information for Cadila Healthcare Ltd., Ahmedabad, India are included.*
FDA Label Image

2eb3ff01 4e61 4397 8042 9ee532e72a80 10

2eb3ff01 4e61 4397 8042 9ee532e72a80 10
The image shows the packaging label for Bosentan Tablets 125 mg by Zydus Lifesciences Limited. It includes an image of a beige, oval tablet marked "447". The label states 60 tablets per package for oral use, with directions for the pharmacist to dispense the Medication Guide. Manufacturer details list Cadila Healthcare Ltd., Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.